AI-Based Pharmacovigilance: A Critical Review of Signal Validity
Pharmacophore · 2026 · 17 (3) · 33-43
DOI: 10.51847/2yq2zv2ejw ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacophore, 2026. Verfasst von Isabella Garcia und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) is increasingly advocated as a solution to the growing volume, complexity, and heterogeneity of pharmacovigilance data, given its ability to process spontaneous reports, electronic health records, narratives, and digital media, which has transformed expectations for drug safety surveillance. Yet, questions remain about whether AI-generated safety signals are valid, unbiased, causally meaningful, and acceptable for regulatory decision-making. This critical review eval
Zitieren
APA
Garcia, I., & Herrera, D. (2026). AI-Based Pharmacovigilance: A Critical Review of Signal Validity. Pharmacophore, 17(3), 33-43. https://doi.org/10.51847/2yq2zv2ejw
Vancouver
Garcia I, Herrera D. AI-Based Pharmacovigilance: A Critical Review of Signal Validity. Pharmacophore. 2026;17(3):33-43. doi:10.51847/2yq2zv2ejw
BibTeX
@article{Garcia2026,
author = {Garcia, Isabella and Herrera, Diego},
title = {AI-Based Pharmacovigilance: A Critical Review of Signal Validity},
journal = {Pharmacophore},
year = {2026},
volume = {17},
number = {3},
pages = {33--43},
doi = {10.51847/2yq2zv2ejw}
}
EUVIMED